Despite the interest in non-medication therapies, including e-therapies, for addressing ADHD, this paper shows that neurofeedback was inferior to methylphenidate in reducing ADHD symptoms.

Purper‐Ouakil, D., Blasco‐Fontecilla, H., Ros, T., Acquaviva, E., Banaschewski, T., Baumeister, S., … & Brandeis, D. (2022). Personalized at‐home neurofeedback compared to long‐acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial. Journal of Child Psychology and Psychiatry, 63(2), 187-198.

https://acamh.onlinelibrary.wiley.com/doi/abs/10.1111/jcpp.13462?campaign=woletoc